Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXps Pensions Regulatory News (XPS)

Share Price Information for Xps Pensions (XPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 264.00
Bid: 264.00
Ask: 266.00
Change: -1.00 (-0.38%)
Spread: 2.00 (0.758%)
Open: 265.00
High: 269.00
Low: 264.00
Prev. Close: 265.00
XPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Expansys Plc

16 Jan 2014 15:59

RNS Number : 8770X
Medical Debenture Investments
16 January 2014
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Medical Debenture Investments

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Expansys Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

16/01/2014

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

48,000,000

4.13

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

48,000,000

4.13

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

ordinary

Purchase

13,550,000

0.645

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

 

Date of disclosure:

16/01/2014

Contact name:

Paul McMahon

Telephone number:

+353872562378

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETSFSFIMFLSEIF
Date   Source Headline
21st Feb 20237:00 amRNSNon-Executive Director Appointment
16th Feb 20232:57 pmRNSDirector/PDMR Shareholding
25th Jan 20233:28 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSInvestor Presentation
1st Dec 20229:40 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:00 amRNSNotice of Half Year Results
26th Oct 202211:13 amRNSDirector/PDMR Shareholding
21st Oct 202211:18 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSPre-close Trading Update
17th Oct 20221:15 pmRNSNotice of pre-close Trading Update
13th Oct 20223:36 pmRNSDirector/PDMR Shareholding
3rd Oct 20221:17 pmRNSTotal Voting Rights and Share Capital
27th Sep 20223:43 pmRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSAcquisition & Trading Update
15th Sep 20227:00 amRNSPensions Awards
13th Sep 20221:43 pmRNSHolding(s) in Company
8th Sep 20223:35 pmRNSResult of AGM
6th Sep 20222:00 pmRNSChairman succession
3rd Aug 20229:53 amRNSDirector/PDMR Shareholding
18th Jul 202212:49 pmRNSBlock Listing Six Monthly Return
18th Jul 202212:45 pmRNSHolding(s) in Company
14th Jul 20229:00 amRNSAnnual Report & Accounts 2021/22 and Notice of AGM
4th Jul 20223:35 pmRNSDirector/PDMR Shareholding
4th Jul 20223:33 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSFull Year Results
15th Jun 20227:00 amRNSNotice of Results
21st Apr 20227:00 amRNSChairman Succession
21st Apr 20227:00 amRNSPre-Close Trading Update and Notice of Results
14th Apr 202212:50 pmRNSHolding(s) in Company
13th Apr 20227:00 amRNSNotice of pre-close Trading Update
8th Mar 20229:00 amRNSXPS forms strategic alliance with abrdn
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Jan 202210:26 amRNSHolding(s) in Company
20th Jan 20224:57 pmRNSDirector/PDMR Shareholding
19th Jan 202210:10 amRNSBlock Listing Six Monthly Review
23rd Dec 20217:00 amRNSProposed acquisition of MJFCA SIPP & SSAS business
17th Dec 20214:36 pmRNSPrice Monitoring Extension
25th Nov 20217:00 amRNSInterim Results
24th Nov 20217:00 amRNSPresentation via Investor Meet Company
23rd Nov 20217:00 amRNSXPS Pensions Group becomes carbon neutral
10th Nov 20217:00 amRNSXPS appointed as pensions advisor to BT Group
14th Oct 20217:00 amRNSPre-close trading update
11th Oct 20217:00 amRNSNotice of pre-close Trading Update
15th Sep 20212:38 pmRNSXPS Pensions Group wins at UK Pensions Awards 2021
10th Sep 20213:04 pmRNSTR-1
10th Sep 202110:25 amRNSDirector Declaration
7th Sep 20213:50 pmRNSResults of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.